Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1247 |
---|---|
Product Name | Anti-Human MET Recombinant Antibody(Onartuzumab) |
Molecular Name | Onartuzumab |
Alias | Anti-MET Recombinant Antibody, Research Grade Onartuzumab |
CAS Number | 1133766-06-9 |
Target | MET[Homo sapiens] |
Isotype | Fab-G1 Kappa -[Fc-G1] |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Buffer | PBS, pH7.5 |
Background | Onartuzumab is a humanized monoclonal antibody designed for the treatment of advanced non-small-cell lung cancer. Onartuzumab was developed by Genentech, Inc. It is undergoing clinical trials. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |